ALOPECIA AREATA(AA)
Clinical trials for ALOPECIA AREATA(AA) explained in plain language.
Never miss a new study
Get alerted when new ALOPECIA AREATA(AA) trials appear
Sign up with your email to follow new studies for ALOPECIA AREATA(AA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Early trial tests new drug for severe hair loss condition
Disease control CompletedThis early-stage study tested the safety and initial effectiveness of an investigational drug called IMG-007 for adults with alopecia areata who had lost at least 50% of their scalp hair. Participants received three intravenous infusions over four weeks and were followed for 20 w…
Matched conditions: ALOPECIA AREATA(AA)
Phase: PHASE1, PHASE2 • Sponsor: Inmagene LLC • Aim: Disease control
Last updated Apr 20, 2026 16:17 UTC
-
Hair loss gene clue? scientists check stress hormone link
Knowledge-focused CompletedThis study examined whether a specific gene (NR3C1) that helps control the body's stress response is linked to alopecia areata, an autoimmune condition that causes hair loss. Researchers compared 120 people with and without the condition to see if certain gene variations were mor…
Matched conditions: ALOPECIA AREATA(AA)
Sponsor: Benha University • Aim: Knowledge-focused
Last updated May 15, 2026 11:54 UTC